Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT5 | O14744 | 1/20 | 0.33 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.33 |
| ▸ | PER2 | O15055 | 2/20 | 0.33 |
| ▸ | CRY2 | Q49AN0 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | USP19 | O94966 | 1/20 | 0.32 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7605032 | 0.88 | ACHE (0.32) | PRMT5WDR77PER2CRY2ACHE | |
| SCHEMBL7608770 | 0.88 | — | — | |
| SCHEMBL7607202 | 0.84 | PIK3CD (0.45) | — | |
| SCHEMBL7603912 | 0.83 | PIK3CD (0.41) | PER2ACHE | |
| SCHEMBL7603122 | 0.83 | PIK3CD (0.37) | PRMT5WDR77PER2CRY2ACHE | |
| SCHEMBL7606074 | 0.82 | PIK3CD (0.40) | PER2ACHE | |
| SCHEMBL7605230 | 0.82 | CHRM2 (0.35) | PRMT5WDR77PER2CRY2ACHE | |
| SCHEMBL6888871 | 0.81 | SMN1; SMN2 (0.41) | PRMT5WDR77PER2CRY2ACHE | |
| SCHEMBL7603856 | 0.81 | CHRM2 (0.35) | PRMT5WDR77PER2CRY2USP19 | |
| SCHEMBL7603320 | 0.80 | PIK3CD (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0934080-B1 | 1,3-BIS-(N-LACTAMYL) PROPANE AND THE PHARMACEUTICAL AND COSMETIC USE THEREOF | BASF AG (DE) | 2002-06-12 | — | — | EP | claimed |
| US-6497886-B1 | SOLVENTS FOR PHARMACEUTICAL PREPARATIONS WHICH, BESIDES EXCELLENT DISSOLVING CAPACITY FOR ACTIVE INGREDIENT USED, ALSO PROVIDE EXCELLENT MISCIBILITY WITH OTHER SOLVENTS AND GOOD PHYSIOLOGICAL TOLERABILITY | BASF AKTIENGESELLSCHAFT (DE) | 2002-12-24 | — | — | US | disclosed |
| EP-0934080-B1 | 1,3-BIS-(N-LACTAMYL) PROPANE AND THE PHARMACEUTICAL AND COSMETIC USE THEREOF | BASF AG (DE) | 2002-06-12 | — | — | EP | disclosed |